Company Overview
Snapshot
Founded in May 2015 by Yagil Netta and Daniel Korkos, Fixnip operates with 1–10 employees. The company has secured funding across one disclosed round from one investor. In May 2022, GC Aesthetics® announced the launch of FixNip™, marking a significant product milestone for the company.
Business overview
Fixnip is a medical device startup specializing in hypodermic silicone nipple implants. The company's core technology combines precise laser cutting, cast molding, and clean room technology with advanced materials like Nitinol and medical silicone to create implants that feel natural while maintaining structural integrity. These implants are designed for post-mastectomy breast reconstruction, inverted nipple repair, and aesthetic enhancement, serving the health tech and life sciences sector.
Strategic signal
In May 2022, GC Aesthetics® announced the launch of FixNip™, highlighting its potential as a significant advancement in breast reconstruction. This launch signals strong market validation and a strategic partnership, indicating Fixnip's readiness to scale its innovative medical device solution within the aesthetic and reconstructive surgery markets.
Log in to access full profile ›Company Intelligence Q&A
- When was Fixnip founded?
- Fixnip was founded in May 2015.
- Who are the founders of Fixnip?
- Fixnip was founded by Yagil Netta and Daniel Korkos.
- What significant product launch did Fixnip announce?
- In May 2022, GC Aesthetics® announced the launch of FixNip™, a hypodermic silicone nipple implant developed by Fixnip for breast reconstruction.
- What is the primary application of Fixnip's technology?
- Fixnip develops hypodermic silicone nipple implants for post-mastectomy breast reconstruction, repair of inverted nipples, and aesthetic enhancement.